News about Global Pharma

WuXi Biologics Extends CRDMO Footprint to Qatar

WuXi Biologics has signed an MoU with the Qatar Free Zones Authority (QFZ) to expand its global footprint into the Middle East. The partnership sets the stage for the company’s first integrated CRDMO centre in the region, strengthening its worldwide research, development, and manufacturing capabilities.

Global Pharma | 02/12/2025 | By Dineshwori |  104

Innovent's PECONDLE Becomes China's First Approved IL-23p19 Antibody

Innovent has received NMPA approval for PECONDLE (picankibart injection), marking China’s first IL-23p19 monoclonal antibody to be cleared for treating moderate-to-severe plaque psoriasis in adults eligible for systemic therapy.

Global Pharma | 02/12/2025 | By Dineshwori

TempraMed Technologies Inks Distribution Agreement with Guri

The partnership marks TempraMed’s entry into a broader global rollout, with the Guri agreement serving as the first step in a series of regional distribution deals planned across Europe, the Middle East, North America, and Asia.

Global Pharma | 28/11/2025 | By Dineshwori

India and Switzerland Explore Pharma-Biotech Collaboration After High-Level Meeting

The talks emphasised avenues for Swiss companies to invest in India’s pharma and biotech industries and to leverage the country’s robust healthcare market.

Global Pharma | 28/11/2025 | By Darshana

Valneva to Further Consolidate its Operations in France

The move is part of Valneva’s strategy to optimise its global footprint, enhance operational efficiency in France, and unify all research and development efforts at its Vienna hub.

Global Pharma | 28/11/2025 | By Dineshwori |  132

Novartis to cut 550 jobs in Switzerland as it shifts focus to cell therapy and advanced biologics

Novartis announced plans to eliminate 550 jobs in Switzerland by the end of 2027 as part of a strategic shift toward cell therapy, RNA-based medicines, and other advanced biologics. The cuts will primarily affect its Stein facility, where the company is phasing out the production of pills, capsules, and sterile medicine packaging.

Global Pharma | 27/11/2025 | By Darshana |  123

Glenmark Launches New Fixed-Dose Triple Therapy for COPD

The treatment combines three medications—an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta-agonist (LABA)—into a single inhaler, aiming to simplify therapy and improve patient adherence.

Global Pharma | 26/11/2025 | By Darshana

Abbott India Gets Central Government Nod for New Managing Director

Abbott India has announced that the Central Government has approved the appointment of Kartik Rajendran as the company’s Managing Director for a five-year term, effective June 14, 2025, to June 13, 2030.

Global Pharma | 24/11/2025 | By Dineshwori |  117

Harbour BioMed, AstraZeneca Advance Next-Gen Oncology Biotherapeutics Collaboration

Harbour BioMed has announced an update on the advancement of its global strategic collaboration with AstraZeneca to discover and develop next-generation biotherapeutics in oncology, including antibody-drug conjugates (ADCs) and T cell engagers.

Global Pharma | 24/11/2025 | By Dineshwori

Shimadzu Medical Systems USA to Unveil MobileDaRt Evolution MX9 Version

Shimadzu Medical Systems USA is set to unveil the MobileDaRt Evolution MX9 Version at the upcoming RSNA Technical Exhibits in Chicago, showcasing enhanced mobility, improved operator visibility, and instant on-board image verification for faster clinical decisions.

Global Pharma | 24/11/2025 | By Dineshwori